5 canonical passages across 5 cases, quoted by 15 opinions in total. These passages cluster together because the same opinions keep quoting them side by side — they state parts of one doctrine. The anchor passage is from Tokai Corp. v. Easton Enterprises, Inc..
| # | Case | Flag | Canonical passage | Citers |
|---|---|---|---|---|
| 1 | Tokai Corp. v. Easton Enterprises, Inc. Anchor | green | “a strong case of prima facie obviousness . . . cannot be overcome by a far weaker showing of objective indicia of nonobviousness.” | 3 |
| 2 | Allergan, Inc. v. Sandoz Inc. | green | “there is no re- quirement in patent law that the person of ordinary skill be motivated to develop the claimed invention based on a rationale that forms the basis for fda approval.” | 3 |
| 3 | Allergan, Inc. v. Apotex Inc. | green | “ilence does not imply teaching away.” | 3 |
| 4 | Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA, Inc. | green | “while secondary considerations must be taken into ac- count, they do not necessarily control the obviousness de- termination.” | 3 |
| 5 | Zup, LLC v. Nash Manufacturing, Inc. | green | “inimal evidence of secondary considerations does not create a genuine dis- pute of fact sufficient to withstand summary judgment on the question of obviousness.” | 3 |
A red or yellow flag on a member means the underlying case has negative treatment — for those, check the case page before relying on the passage.